Regulatory Coordinator 2 - Clinical Trial Office

The Regulatory Coordinator II (RC II) will work directly for the Clinical Trials Office to complete the FDA regulatory requirements for Investigational New Drug (IND) clinical research studies. The RC coordinates aspects of FDA submissions, prepares and submits regulatory documents, and maintains records on assigned INDs to ensure regulatory compliance with DFCI and HCC policies as well as federal regulation and ICH/GCP guidelines. This position will work collaboratively with a variety of personnel at all levels, including faculty and study team members of HCC and external institutions, cooperative groups, clinical trials experts, representatives from the pharmaceutical industry, federal agencies, and other research organizations. Works interactively with the Office for Human Research Studies (OHRS), Office of Data Quality (ODQ) and the Clinical Trials Offices at the various DF/HCC institutions when applicable.

The Institutional IND Regulatory Coordinator works directly for the Clinical Trials Office to complete and oversee FDA regulatory requirements specific to vaccine research or other critical DFCI-developed research products. This position serves as the primary reporting contact for the Institutional IND portfolio managed by the CTO Regulatory Affairs Core. The Institutional IND RC centrally prepares, submits, and maintains records on assigned INDs to ensure regulatory compliance with all Food and Drug Administration (FDA), National Institutes of Health Office of Science Policy (NIH OSP), and institutional biosafety committee (IBC) requirements. This position works collaboratively with various departments within DFCI and the other HCC institutions, as well as with representative from federal agencies. As necessary, the Institutional IND RC assists the CTO Regulatory Affairs Core with other required submissions to FDA, yearly Principal Investigator Worksheet (PIW) updates for DFCI physicians participating in National Cancer Institute (NCI) research, regulatory binder reviews for audit/inspection preparations, and other regulatory or compliance initiatives.

This position's work location is fully remote with occasional time on-campus in Brookline, MA. The selected candidate may only work remotely from a New England state (ME, VT, NH, MA, CT, RI).

Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
 

• Prepares and submits all protocol applications, amendments, continuing reviews, and informed consent documents for SRC and IRB review and approval.
• Assists in the preparation and coordination of assigned study monitoring and auditing visits with study coordinator, Investigator, DF/HCC ODQ, Industry Sponsors, and third-party auditors.
• Maintains various regulatory tracking databases with information related to study recruitment, subject enrollment, and study progress and completion.
• Prepares, maintains and organizes Regulatory files for each assigned study in compliance with study sponsor requirement; Industry sponsor, DF/HCC sponsored etc.
• Prepares and submits regulatory documentation that may include IND/IDE applications, FDA annual reports, Serious Adverse Event reports, to the appropriate regulatory agencies including the Food and Drug Administration (FDA), Office of Biotechnology Activities (OBA), etc.
• Track and manage assigned new protocol start-up packet; initiate, facilitate, and monitor study start-up progress to ensure established benchmarks are met.
• Communicate and collaborate with clinical trial key stakeholders through the start-up process, provide regular updates and ensure all start-up activities are completed.
• Create and maintain tracking for all subsequent submissions to the SRC/IRB; protocol & consent amendments, all required safety reporting, all required deviation, violation, exception, or other event reporting. Ensure various regulatory reporting required are met, Study Sponsor, FDA, IRB etc.
• Establishing and maintaining regular communication with study team, study sponsor, applicable regulatory agencies / offices to ensure all required information is relayed and responsible for the systematic documentation / tracking when applicable.
• Serve as facilitator for study team and sponsor regarding study status information, critical safety issues, upcoming protocol, consent and IDB amendments and applicable protocol training; responsible for the systematic documentation / tracking when applicable.
• Maintain working knowledge of current regulations, regulatory guidance and or local policies.
• Assists Clinical Research Manager with regulatory based training and implementation of new or revised regulation, guidance and or local policy.
• Present regulatory status for disease group portfolio at applicable research meetings.

KNOWLEDGE, SKILLS, AND ABILITIES REQUIRED: 

• Must possess excellent written and oral communication skills, maintain confidentiality of information, demonstrate good decision-making and judgment and have attention to detail and follow-through skills
• Demonstrated organization and time management/prioritization skills with the ability to work independently are required
• Must be proficient in the use of computers, Microsoft applications and databases
• Requires experience with medical terminology

MINIMUM JOB QUALIFICATIONS:

• The position requires a bachelor’s degree or 2 years of experience as a Dana-Farber Regulatory Coordinator, along with 1-3 years of direct regulatory experience.
• Candidates must have intermediate to advanced knowledge of FDA and ICH/GCP guidelines and previous experience with clinical trials or research coordination.

SUPERVISORY RESPONSIBILITIES: No direct supervisory responsibility may have a role in training new regulatory coordinators

PATIENT CONTACT: None

At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are committed to having faculty and staff who offer multifaceted experiences. Cancer knows no boundaries and when it comes to hiring the most dedicated and compassionate professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.

Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.  

EEO Poster

.

Pay Transparency Statement

The hiring range is based on market pay structures, with individual salaries determined by factors such as business needs, market conditions, internal equity, and based on the candidate’s relevant experience, skills and qualifications.

For union positions, the pay range is determined by the Collective Bargaining Agreement (CBA).

$61,110.00 - $67,900.00